Bactimicina Cough And Cold Solution
NDC Package 24286-1546-4
Package Information
Bactimicina Cough And Cold (dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride) solution is do not take more than 6 doses in any 24-hour periodthis adult product is not intended for children under 12 years oldAge (years)Dose12 and over2 teaspoons (10 mL) every 4 hoursUnder 12do not use. This formulation utilizes a solution delivery system. Marketed by Dlc Laboratories, Inc., this product is identified by NDC 24286-1546 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1044949 - dextromethorphan HBr 20 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 10 mL Oral Solution
- RxCUI: 1044949 - dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution
- RxCUI: 1044949 - dextromethorphan HBr 10 MG / guaifenesin 100 MG / phenylephrine HCl 5 MG per 5 ML Oral Solution
- RxCUI: 1044949 - dextromethorphan HBr 20 MG / guaifenesin 200 MG / phenylephrine HCl 10 MG per 10 ML Oral Solution
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 24286 - Dlc Laboratories, Inc.
- 24286-1546 - Bactimicina Cough And Cold
- 24286-1546-4 - 1 BOTTLE in 1 BOX / 118 mL in 1 BOTTLE
- 24286-1546 - Bactimicina Cough And Cold
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 24286-1546-4 identifies a specific commercial package of 1 bottle in 1 box / 118 ml in 1 bottle of Bactimicina Cough And Cold, a human over the counter drug labeled by Dlc Laboratories, Inc.. This solution is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dlc Laboratories, Inc. on November 06, 2013. The current certification is valid through December 31, 2027.
How is this Dlc Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 24286154604. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.